Trials / Completed
CompletedNCT00444795
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 520 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To monitor use in real practice including adverse events and efficacy on Sutent capsules (Sunitinib malate)
Detailed description
All the patients prescribed according to approved indications at contracted institutions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sunitinib malate | Sunitinib : dosing not pre-determined |
| DRUG | Sunitinib malate | Sunitinib : dosing not pre-determined |
| DRUG | sunitinib malate | Sunitinib : dosing not pre-determined |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2007-03-08
- Last updated
- 2017-02-01
- Results posted
- 2016-04-26
Locations
47 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00444795. Inclusion in this directory is not an endorsement.